Allogene Therapeutics, Inc. Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allogene Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Allogene Therapeutics, Inc. for July 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Option Exercise | M | 2.27 | 11,819 | 26,829 | 767,029 | |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Option Exercise | M | 2.27 | 23,815 | 54,060 | 778,848 | |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Option Exercise | M | 2.27 | 13,193 | 29,948 | 802,663 | |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Sell | S | 29.85 | 11,819 | 352,738 | 65,373 | 77.2 K to 65.4 K (-15.31 %) |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Buy | M | 2.27 | 11,819 | 26,829 | 77,192 | 65.4 K to 77.2 K (+18.08 %) |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Sell | S | 29.39 | 23,815 | 699,870 | 65,373 | 89.2 K to 65.4 K (-26.70 %) |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Buy | M | 2.27 | 23,815 | 54,060 | 89,188 | 65.4 K to 89.2 K (+36.43 %) |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Sell | S | 29.18 | 13,193 | 384,994 | 65,373 | 78.6 K to 65.4 K (-16.79 %) |
| Jul 30 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Buy | M | 2.27 | 13,193 | 29,948 | 78,566 | 65.4 K to 78.6 K (+20.18 %) |
| Jul 22 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Buy | J | 0.00 | 8,217 | 0 | 1,420,835 | 1.4 M to 1.4 M (+0.58 %) |
| Jul 22 2019 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 9,391 | 0 | 2,186,078 | 2.2 M to 2.2 M (+0.43 %) |
| Jul 22 2019 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 9,402 | 0 | 1,144,900 | 1.1 M to 1.1 M (+0.83 %) |
| Jul 12 2019 | ALLO | Allogene Therapeut ... | Kazam Joshua A | Director | Buy | J | 0.00 | 5,590 | 0 | 1,412,618 | 1.4 M to 1.4 M (+0.40 %) |
| Jul 12 2019 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 6,388 | 0 | 2,176,687 | 2.2 M to 2.2 M (+0.29 %) |
| Jul 12 2019 | ALLO | Allogene Therapeut ... | Chang David D | President and CEO | Buy | J | 0.00 | 10,154 | 0 | 1,135,498 | 1.1 M to 1.1 M (+0.90 %) |
| Jul 01 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Option Exercise | M | 2.27 | 27,816 | 63,142 | 815,856 | |
| Jul 01 2019 | ALLO | Allogene Therapeut ... | MOORE ALISON | Chief Technical Off ... | Buy | M | 2.27 | 27,816 | 63,142 | 65,373 | 37.6 K to 65.4 K (+74.06 %) |